US2006276444A1PendingUtilityA1
Porphyrin-polyamine conjugates for cancer therapy
Est. expiryJun 26, 2022(expired)· nominal 20-yr term from priority
Inventors:Benjamin FrydmanLinda CliffordAldonia ValasinasVenodhar K. ReddyHirak S. BasuAparajita SarkarSubhra BhattacharyaYu WangLaurence J. MartonAndrei V. Blokhin
A61P 35/00C07D 487/22
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Porphyrin-polyamine conjugate compounds are disclosed which have anticancer and antitumor effects. The porphyrin moiety selectively localizes in tumors, while the polyamine moiety serves as a cytotoxic agent. Methods of making and using the porphyrin-polyamine conjugate compounds are also disclosed.
Claims
exact text as granted — not AI-modified1 . A composition comprising a compound according to the formula
wherein at least one of J 1 , J 2 , J 3 , J 4 , J 5 , J 6 , J 7 and J 8 is independently selected from the group consisting of
—(B-A-B) x -G-(B-A-B) m —(N(P)—B-A-B) n —K.
wherein each A is independently selected from the group consisting of: a nonentity, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, C 3 -C 12 cycloalkyl, C 3 -C 8 cycloaryl, C 3 -C 12 cycloalkenyl, C 3 -C 12 cycloalkynyl, C 1 -C 12 alkanol, C 3 -C 12 cycloalkanol, and C 3 -C 8 hydroxyaryl;
each B is independently selected from the group consisting of: a nonentity, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, C 3 -C 12 cycloalkyl, C 3 -C 8 cycloaryl, C 3 -C 12 cycloalkenyl, C 3 -C 12 cycloalkynyl, C 1 -C 12 alkanol, C 3 -C 12 cycloalkanol, and C 3 -C 8 hydroxyaryl;
and with the proviso that each —B-A-B— unit contain at least one carbon atom;
wherein G is independently selected from the group consisting of —N(P)—, —(C═O)—N(P)—, —N(P)—(C═O)—, and a nonentity;
x is independently 0 or 1;
m is independently 0 or 1;
n is independently an integer from 0 to 20;
each P is independently selected from the group consisting of H and C 1 -C 12 alkyl;
each K is independently selected from the group consisting of H, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, C 3 -C 12 cycloalkyl, C 3 -C 8 cycloaryl, C 3 -C 12 cycloalkenyl, C 3 -C 12 cycloalkynyl, C 1 -C 12 alkanol, C 3 -C 12 cycloalkanol, and C 3 -C 8 hydroxyaryl, and Q;
where each Q is independently selected from the group consisting of
where each P is independently selected from the group consisting of H and C 1 -C 12 alkyl, each D is selected from the group consisting of H and C 1 -C 32 alkyl, y is an integer from 1 to 8, and z is an integer from 0 to 5, and where the Q moiety is attached to the remainder of the molecule at any C or N atom in the Q moiety (including C atoms in the D or P moieties) by removing a hydrogen atom, a P substituent, or a D substituent of the Q moiety to form an open valence for attachment to the remainder of the molecule;
and where the remaining members or member of J 1 , J 2 , J 3 , J 4 , J 5 , J 6 , J 7 and J 8 are each independently selected from the group consisting of H, —B-A-B, —COOH, —SO 3 H, —B-A-B—COOH, or —B-A-B—SO 3 H, where each A and each B are independently selected as defined above and with the proviso that each —B-A-B— unit has at least one carbon atom.
2 . A composition comprising a compound according to the formula
wherein at least one of J 1 , J 2 , J 3 , J 4 , J 5 , J 6 , J 7 and J 8 is independently M, where each M is independently selected from the group consisting of
—(B-A-B) x -G-(B-A-B) m —(N(P)—B-A-B) n —K
wherein each A is independently selected from the group consisting of: a nonentity, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, C 3 -C 12 cycloalkyl, C 3 -C 8 cycloaryl, C 3 -C 12 cycloalkenyl, C 3 -C 12 cycloalkynyl, C 1 -C 12 alkanol, C 3 -C 12 cycloalkanol, and C 3 -C 8 hydroxyaryl;
each B is independently selected from the group consisting of: a nonentity, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, C 3 -C 12 cycloalkyl, C 3 -C 8 cycloaryl, C 3 -C 12 cycloalkenyl, C 3 -C 12 cycloalkynyl, C 1 -C 12 alkanol, C 3 -C 12 cycloalkanol, and C 3 -C 8 hydroxyaryl;
and with the proviso that each —B-A-B— unit contain at least one carbon atom;
wherein G is independently selected from the group consisting of —N(P)—, —(C═O)—N(P)—, —N(P)—(C═O)—, and a nonentity;
x is independently 0 or 1;
m is independently 0 or 1;
n is independently an integer from 0 to 20;
each P is independently selected from the group consisting of H and C 1 -C 12 alkyl;
each K is independently selected from the group consisting of H, C 1 -C 12 alkyl, C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, C 3 -C 12 cycloalkyl, C 3 -C 8 cycloaryl, C 3 -C 12 cycloalkenyl, C 3 -C 12 cycloalkynyl, C 1 -C 12 alkanol, C 3 -C 12 cycloalkanol, and C 3 -C 8 hydroxyaryl, and Q;
where each Q is independently selected from the group consisting of
where each P is independently selected from the group consisting of H and C 1 -C 12 alkyl, each D is selected from the group consisting of H and C 1 -C 32 alkyl, y is an integer from 1 to 8, and z is an integer from 0 to 5, and where the Q moiety is attached to the remainder of the molecule at any C or N atom in the Q moiety (including C atoms in the D or P moieties) by removing a hydrogen atom, a P substituent, or a D substituent of the Q moiety to form an open valence for attachment to the remainder of the molecule;
and where the remaining members or member of J 1 , J 2 , J 3 , J 4 , J 5 , J 6 , J 7 and J 8 are each independently selected from the group consisting of H, —B-A-B, —COOH, —SO 3 H, —B-A-B—COOH, or —B-A-B—SO 3 H, where each A and each B are independently selected as defined above and with the proviso that each —B-A-B— unit has at least one carbon atom;
with the proviso that M excludes moieties of the form
—K 1 -G 5 -L 5 -(N(P 5 )-A 5 ) n -K 2
where K 1 is independently selected from the group consisting of C 1 -C 8 alkyl and where the valence to the left of K 1 attaches to the porphyrin ring;
G 5 is —O—, —(C═O)—, —C(═O)—O—, —O—(C═O)—, —O—(C═O)—O—, —O—(C═O)—N—, —N—(C═O)—O—, or a nonentity;
L 5 is C 1 -C 8 alkyl, C 3 -C 8 cycloalkyl, C 3 -C 8 cycloaryl, C 1 -C 8 alkoxy, C 1 -C 8 alkyl-C 3 -C 8 cycloalkyl, C 1 -C 8 alkyl-C 3 -C 8 cycloaryl, C 1 -C 8 alkoxy-C 3 -C 8 cycloaryl, C 3 -C 8 cycloalkyl-C 3 -C 8 cycloaryl, C 3 -C 8 cycloalkyl-C 1 -C 8 alkyl, C 3 -C 8 cycloaryl-C 1 -C 8 alkyl, C 3 -C 8 cycloaryl-C 1 -C 8 alkoxy, C 3 -C 8 cycloaryl-C 3 -C 8 cycloalkyl, or a nonentity;
each A 5 is independently selected from the group consisting of C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 3 -C 8 cycloalkyl, C 3 -C 8 cycloaryl, C 3 -C 8 cycloalkenyl, and C 3 -C 8 cycloalkynyl;
P 5 is selected from the group consisting of H and C 1 -C 8 alkyl;
n is an integer from 2 to 8;
and K 2 is independently selected from the group consisting of H, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 3 -C 8 cycloalkyl, C 3 -C 8 cycloaryl, C 3 -C 8 cycloalkenyl, C 3 -C 8 cycloalkynyl, C 1 -C 8 alkanol, C 3 -C 8 cycloalkanol, and C 3 -C 8 hydroxyaryl.
3 . The composition of claim 2 , where G is independently selected from —(C═O)—N(P)— and —N(P)—(C═O)—.
4 . The composition of claim 2 , where the Q moiety is attached to the remainder of the molecule at any N atom in the Q moiety by removing a P substituent of the Q moiety to form an open valence for attachment to the remainder of the molecule.
5 . The composition of claim 2 , wherein each A and B substituent, if present, is selected from C 1 -C 12 alkyl.
6 . The composition of claim 2 , wherein at least one A substituent comprises a cyclopropane group.
7 . The composition of claim 2 comprising a compound of the formula
where J 1 and J 2 are independently M and each M is independently selected from the group consisting of —(B-A-B) x -G-(B-A-B) m —(N(P)—B-A-B) n —K;
J 3 , J 4 , J 6 and J 8 are independently selected from methyl and ethyl; and
J 5 and J 7 are independently selected from methyl, ethyl, and —SO 3 H.
8 . The composition of claim 7 , where J 1 and J 2 are independently M and each M is independently selected from the group consisting of
—(B-A-B)-G-(B-A-B)—(N(P)—B-A-B) n —K.
9 . The composition of claim 8 , wherein at least one B-A-B unit comprises a cycloalkyl moiety.
10 . The composition of claim 9 , wherein at least one B-A-B unit comprises a cyclopropyl moiety.
11 . The composition of claim 7 , where J 1 and J 2 are independently M and each M is independently selected from the group consisting of —C 1 -C 12 alkyl-G-C 1 -C 12 alkyl-(N(P)—B-A-B) n —K.
12 . The composition of claim 7 , where J 1 and J 2 are independently M and each M is independently selected from the group consisting of —C 1 -C 12 alkyl-(C═O)—N(P)—C 1 -C 12 alkyl-(N(P)—B-A-B) n —K.
13 . The composition of claim 7 , where J 1 and J 2 are independently M and each M is independently selected from the group consisting of —(CH 2 ) 2 C(═O)N(P 2 )—C 1 -C 4 alkyl-[NH(CH 2 CH 2 CH 2 CH 2 )] f C 1 -C 12 alkyl, where P 2 is H, methyl, or ethyl, and f is an integer from 1 to 10.
14 . The composition of claim 10 , where J 1 and J 2 are identical.
15 . The composition of claim 11 , where J 1 and J 2 are identical.
16 . The composition of claim 1 , wherein each —K is independently Q;
where each Q is independently selected from the group consisting of wherein only one D moiety is selected from the group consisting of C 1 -C 32 alkyl and all remaining D moieties are H; wherein three P groups are selected from the group consisting of —H and —CH 3 ; wherein the fourth P group is absent and the Q moiety is attached to the remainder of the molecule at that valence; and wherein y is 2, 3, or 4 and z is 0, 1; or 2.
17 . The composition of claim 2 , wherein each —K is independently Q;
where each Q is independently selected from the group consisting of wherein only one D moiety is selected from the group consisting of C 1 -C 32 alkyl and all remaining D moieties are H; wherein three P groups are selected from the group consisting of —H and —CH 3 ; wherein the fourth P group is absent and the Q moiety is attached to the remainder of the molecule at that valence; and wherein y is 2, 3, or 4 and z is 0, 1, or 2.
18 . The composition of claim 6 , wherein each —K is independently Q;
where each Q is independently selected from the group consisting of wherein only one D moiety is selected from the group consisting of C 1 -C 32 alkyl and all remaining D moieties are H; wherein three P groups are selected from the group consisting of —H and —CH 3 ; wherein the fourth P group is absent and the Q moiety is attached to the remainder of the molecule at that valence; and wherein y is 2, 3, or 4 and z is 0, 1, or 2.
19 . The composition of claim 1 , wherein —K is
20 . The composition of claim 2 , wherein —K isCited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.